Compare Innovative Industrial Properties Inc (IIPR) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Innovative Industrial Properties Inc vs Zoetis Inc — how do they compare? Innovative Industrial Properties Inc trades at $62.11 (market cap $1.83B), while Zoetis Inc trades at $74.04 (market cap $31.59B). The key difference: Zoetis Inc is far larger — about 17.3× Innovative Industrial Properties Inc's market cap, and Innovative Industrial Properties Inc pays the higher dividend (12.01%). Which is the better fit depends on your goals.
| IIPR | ZTS | |
|---|---|---|
Market Cap | $1.83B | $31.59B |
Sector | Real Estate | Health |
52-Week High | $64.67 | $156.76 |
52-Week Low | $44.58 | $71.91 |
Enterprise Value | $2.22B | $38.89B |
Dividend Yield | 12.01% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IIPR trades at $63.25, down 1.89% today, with a bullish technical signal from moving averages. The REIT shows strong profitability with 88.46% gross margins and 45.58% net income margin, though revenue declined to $266M in 2025. Recent news highlights successful debt refinancing and upcoming Q2 2026 earnings on August 3rd, with analyst consensus leaning Hold (54.55%).
The outlook remains cautious due to revenue declines and mixed earnings performance, but strong margins and recent capital structure improvements provide stability. Key risks include cannabis sector volatility and tenant credit quality, while the 9% dividend yield offers income appeal. Wall Street sentiment is neutral with balanced risk-reward.
Zoetis (ZTS) trades at $75.33, down 1.61% amid mixed technical signals and ongoing securities litigation. The stock shows strong fundamentals with a 28.03% net margin and 67.75% ROE, supported by consistent revenue growth from $8.1B in 2022 to $9.47B in 2025. Recent earnings beat expectations in Q3 and Q4 2025 but missed in Q1 2026, with Q2 results pending. Analyst consensus remains positive with a $101.43 price target, though technical indicators show neutral momentum near key support at $75.
The outlook for ZTS is cautiously optimistic given robust profitability and analyst support, but significant legal overhangs and recent earnings volatility present near-term risks. Long-term growth in animal health markets offers upside, yet investors should monitor litigation developments and Q2 earnings for directional cues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Innovative Industrial Properties Inc
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
